A detailed history of Delta Financial Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Delta Financial Advisors LLC holds 16,059 shares of ABT stock, worth $1.69 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
16,059
Previous 16,029 0.19%
Holding current value
$1.69 Million
Previous $1.76 Million 3.46%
% of portfolio
0.72%
Previous 0.77%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$109.52 - $120.96 $3,285 - $3,628
30 Added 0.19%
16,059 $1.83 Million
Q4 2023

Jan 31, 2024

SELL
$90.19 - $110.4 $14,250 - $17,443
-158 Reduced 0.98%
16,029 $1.76 Million
Q3 2023

Nov 03, 2023

BUY
$95.53 - $114.62 $12,514 - $15,015
131 Added 0.82%
16,187 $1.57 Million
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $7,256 - $8,084
-72 Reduced 0.45%
16,056 $1.75 Million
Q1 2023

May 04, 2023

SELL
$96.86 - $114.01 $37,291 - $43,893
-385 Reduced 2.33%
16,128 $1.63 Million
Q4 2022

Feb 01, 2023

SELL
$95.06 - $111.52 $2,091 - $2,453
-22 Reduced 0.13%
16,513 $1.81 Million
Q3 2022

Oct 27, 2022

BUY
$96.76 - $112.03 $2,515 - $2,912
26 Added 0.16%
16,535 $1.6 Million
Q2 2022

Aug 01, 2022

SELL
$102.07 - $123.37 $7,655 - $9,252
-75 Reduced 0.45%
16,509 $1.79 Million
Q1 2022

May 06, 2022

BUY
$114.02 - $139.04 $2,736 - $3,336
24 Added 0.14%
16,584 $1.96 Million
Q4 2021

Feb 04, 2022

BUY
$115.53 - $141.46 $1,270 - $1,556
11 Added 0.07%
16,560 $2.33 Million
Q3 2021

Oct 26, 2021

SELL
$116.66 - $129.06 $20,998 - $23,230
-180 Reduced 1.08%
16,549 $1.96 Million
Q2 2021

Aug 04, 2021

SELL
$105.79 - $124.53 $16,185 - $19,053
-153 Reduced 0.91%
16,729 $1.94 Million
Q1 2021

Apr 29, 2021

BUY
$108.84 - $128.23 $2,285 - $2,692
21 Added 0.12%
16,882 $2.02 Million
Q4 2020

Jan 28, 2021

SELL
$105.0 - $114.42 $19,320 - $21,053
-184 Reduced 1.08%
16,861 $1.85 Million
Q3 2020

Oct 20, 2020

SELL
$91.64 - $111.29 $22,910 - $27,822
-250 Reduced 1.45%
17,045 $1.86 Million
Q2 2020

Aug 04, 2020

SELL
$76.57 - $98.0 $70,597 - $90,356
-922 Reduced 5.06%
17,295 $1.58 Million
Q1 2020

Apr 27, 2020

SELL
$62.82 - $91.86 $577,190 - $844,009
-9,188 Reduced 33.53%
18,217 $1.44 Million
Q4 2019

Feb 06, 2020

SELL
$78.51 - $87.4 $20,805 - $23,161
-265 Reduced 0.96%
27,405 $2.38 Million
Q3 2019

Oct 30, 2019

SELL
$81.84 - $88.74 $18,905 - $20,498
-231 Reduced 0.83%
27,670 $2.32 Million
Q2 2019

Oct 11, 2019

BUY
$72.88 - $85.0 $2.03 Million - $2.37 Million
27,901 New
27,901 $2.35 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $184B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Delta Financial Advisors LLC Portfolio

Follow Delta Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Advisors LLC with notifications on news.